George Scangos' Bold Vision Post author:Sam Post published:October 24, 2017 Post category:BioPharma The former Biogen CEO is making waves at his new venture, Vir Biotechnology. Source: BioSpace You Might Also Like And It Begins…Looks to Cut $1.2 Billion of NIH R&D Spending This Year March 28, 2017 Certara Corporation's Partners With To Audit The Nation???s Medical Countermeasures Preparedness April 4, 2017 3 Broker Favorite Biopharmas Your Portfolio Must Have January 17, 2018
Certara Corporation's Partners With To Audit The Nation???s Medical Countermeasures Preparedness April 4, 2017
